Assessment of interleukin-10 level and Janus kinase 2 V617F mutation incidence in patients with primary myelofibrosis

Assessment of interleukin-10 level and Janus kinase 2 V617F mutation incidence in patients with primary myelofibrosis

Background: Myelofibrosis (MF) is largely documented by an abnormal cytokine expression, which in turn could contribute to bone marrow fibrosis, angiogenesis, and constitutional symptoms. To gain additional pathogenetic insight regarding cytokine phenotype correlations in MF, this study estimated th...

Full description

Bibliographic Details
Main Author: Shahla′a Fadhil Sabir
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Iraqi Journal of Hematology
Subjects:
Interleukin-10
Janus kinase 2 V617F mutation
myelofibrosis
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2016;volume=5;issue=2;spage=178;epage=182;aulast=Sabir

Similar Items

Similar Items